Week in Review: Agilent Pays $250 Million To Acquire ACEA And Its Cell Therapy Analyzer

ACEA Biosciences, a San Diego company with R&D and manufacturing facilities in Hangzhzou, will be acquired by Agilent for $250 million in cash. ACEA developed the xCELLigence® cell therapy analysis device used by academic and biopharma researchers.